"Natural History" Study of Choroideremia
NCT02994368 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 57
Last updated 2022-01-06
Summary
The purpose of this study is to understand the rate of progression of all stages of choroideremia using a variety of assessments performed in the clinic including visual field measures, specialized photography of the eye and participant-reported visual problems
Conditions
- Choroideremia
Interventions
- OTHER
-
Observation
Sponsors & Collaborators
-
4D Molecular Therapeutics
lead INDUSTRY
Principal Investigators
-
Schonmei Lee, MD · 4D Molecular Therapeutics
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2021-10-31
- Completion
- 2021-10-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Screening Patients With Sickle Cell Disease for Kidney Damage
NCT02239016 ·Status: COMPLETED
-
Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease
NCT02394431 ·Status: COMPLETED
-
Longitudinal Study of the Porphyrias
NCT01561157 ·Status: RECRUITING
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease
NCT01123369 ·Status: COMPLETED
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy
NCT01956799 ·Status: COMPLETED
-
Exploring Adherence Monitoring in Sickle Cell Disease
NCT03708731 ·Status: ACTIVE_NOT_RECRUITING
-
Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients
NCT05649280 ·Status: COMPLETED
-
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
NCT00004492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study)
NCT03446586 ·Status: UNKNOWN
-
Natural History Study of Adult Patients With Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis in China
NCT05125341 ·Status: COMPLETED
-
Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
NCT00004940 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
NCT00395629 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women
NCT02683369 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Signs and Symptoms of Anemia in Patients Over 75 Years
NCT02662699 ·Status: UNKNOWN
-
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
NCT01905787 ·Status: UNKNOWN
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Carbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without Hemolysis
NCT01848691 ·Status: COMPLETED ·Phase: NA
-
The Implementation of the Automated Erythrocytapheresis in Egyptian Sickle Cell Disease Center
NCT03903289 ·Status: RECRUITING ·Phase: NA
-
Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel
NCT00481039 ·Status: COMPLETED
-
Oxidative Stress and Iron Overload in Patient With Abnormal Haemoglobinopathy
NCT05586932 ·Status: UNKNOWN
-
Study to Assess SLN124 in Patients With Polycythemia Vera
NCT05499013 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety of Single Doses of CSL889 in Adult Patients With Sickle Cell Disease
NCT04285827 ·Status: COMPLETED ·Phase: PHASE1
-
Hemoglobin Easy Measurement With Optical Artificial Intelligence
NCT04573244 ·Status: COMPLETED